(Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced that Jim Wang, Ph.D., has been ...
https://www.google.com/url?rct=j&sa=t&url=https://www.globenewswire.com/news-release/2021/08/23/2284896/32452/en/Adverum-Appoints-Global-Regulatory-Leader-Jim-Wang-Ph-D-as-Senior-Vice-President-Head-of-Regulatory-Affairs.html&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNG6OzShJgF2ZMAFiLHvfnsLxk3KsA
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.